Rates of cataracts and glaucoma trended higher in the group controlled on infliximab than on adalimumab Q1 week, although this did not reach statistical significance
Rates of cataracts and glaucoma trended higher in the group controlled on infliximab than on adalimumab Q1 week, although this did not reach statistical significance. also includes adalimumab Q1 week as a treatment option.6 However, the efficacy of Q1 week dosing of Rabbit polyclonal to ZNF697 adalimumab in children has not been evaluated formally. We conducted a single-center review to assess the effectiveness of adalimumab Q1 week in treating uveitis refractory to adalimumab Q2 weeks, compared with patients switched to infliximab, a chimeric monoclonal antiCTNF- antibody administered intravenously, as reference. METHODS We conducted a review of medical records from children with chronic noninfectious uveitis treated with adalimumab Q2 weeks who switched to adalimumab Q1 week or monthly infliximab due to persistent uveitis. Medical records for patients seen in the Boston…